Novartis AG (VIE:NOVN)

Market Cap	217.42B
Revenue (ttm)	48.05B
Net Income (ttm)	12.27B
Shares Out	n/a
EPS (ttm)	6.22
PE Ratio	17.72
Forward PE	15.10
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1
Open	113.76
Previous Close	114.68
Day's Range	113.34 - 113.94
52-Week Range	94.21 - 114.68
Beta	n/a
RSI	63.40
Earnings Date	Oct 28, 2025

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiotensin receptorneprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx to treat plaque psoriasis, pso riatic arthritis, ankylosing spondylitis, and nonradiographic axial spondy loarthritis; Kisqali, a selective oral cyclin dependent inhibitor of kinases 4 and 6 (CDK4/6); Promacta/Revolade to treat immune thrombocy...

• Industry: Pharmaceutical Preparations
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: NOVN

Financial Performance

In 2024, Novartis AG's revenue was $51.72 billion, an increase of 10.85% compared to the previous year's $46.66 billion. Earnings were $11.94 billion, a decrease of -19.59%.

Financial numbers in USD